MedPath

E-MAX 2nd Gen Vit E Poly On BIOLOX Delta Ceramic Heads

Conditions
In Need of a Total Hip Arthroplasty
Registration Number
NCT01943149
Lead Sponsor
Renovis Surgical Technologies, Inc.
Brief Summary

The purpose of this study is to monitor outcomes of total hip arthroplasties performed with E-MAX polyethylene and BIOLOX Delta Ceramic head. Polyethylene has been used as a bearing surface in total joint replacements for half of a century. Radiation, the most common form of sterilization, unfortunately it results in the creation of free radicals (atoms or molecules that cause chemical reactions with other substances) within the materials which cause the breakdown of the polyethylene. Second generation antioxidant polyethylene, Renovis E-MAX, mechanically blends in Vitamin E as an antioxidant. This helps eliminate free radicals while maintaining mechanical strength. The theory is that E-MAX will be a safe and long lasting bearing surface in total hip arthroplasty that meets or exceeds current wear rates after being placed in a patient.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patient is under 65 years of age
  • Patient's health status qualifies as ASA 1 or ASA 2
  • Patient is willing to commit to long term follow (study duration is 10 yrs)
Exclusion Criteria
  • Allergy to any materials used in hip implant
  • Unwillingness to participate in long term follow-up
  • Diagnosis of inflammatory arthritis
  • Simultaneous bilateral total hip arthroplasty is recommended.
  • Patient's health status qualifies as ASA 3 or greater.
  • Patient is over the age of 65 of age

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
E-Max liner wear rateChange from baseline to 10 years post-operative

This measure's purpose it to look at the longevity of our product. Radiographs will be taken at standard checkpoints over the course of 10 years. Radiographic analysis will be done to assess wear rates of the E-Max liner over the course of the 10 year study. Wear rates will then be compared to other products that have already been studied and published in hopes of finding that E-Max's wear rates are at least as good if not better than comparative products on the market.

Secondary Outcome Measures
NameTimeMethod
Patient Function and MobilityChange from Pre-operative to 10 years post-operative

This measure will assess patient function and mobility preoperatively and compare this at standard checkpoints over 10 years post-operatively. This will be done through use of the Harris Hip Score and UCLA Functional Assessment with the hope of seeing improvement in both over the course of time.

Trial Locations

Locations (1)

Cornerstone Orthopedics

🇺🇸

Louisville, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath